F9 and hemophilia B: The influence of molecular determinants have been deeply investigated in the model disease hemophilia B. Expression studies were conducted on an ample panel of PTCs (n = 11) representing the most frequent F9 nonsense mutations, including all recurrent UGA PTCs at CpG sites, reported in ~70% (324 out of 469) patients with severe hemophilia B [161].